Faron Pharmaceuticals reports new data for cancer drug Clevegen
Faron Pharmaceuticals has reported new findings from the open-label Phase I/II MATINS clinical trial of its cancer immunotherapy Clevegen for…
Faron Pharmaceuticals has reported new findings from the open-label Phase I/II MATINS clinical trial of its cancer immunotherapy Clevegen for…
Faron Pharmaceuticals said clinical results from a study for the treatment of acute respiratory distress syndrome (ARDS) showed that the…
Bayer and Orion have reported positive results from a Phase III clinical trial (ARAMIS) of darolutamide in patients with non-metastatic…
DelSiTech has signed an agreement with Innovare for the development of long-acting human immunodeficiency virus (HIV) therapeutics.
Zealand Pharma has sold its future royalty streams and potential commercial milestones for Soliqua® 100/33/Suliqua® and Lyxumia®/Adlyxin® to Royalty Pharma…
Tongyang Networks Corporation has acquired a 29.72% stake in biotechnology company MediGene for KRW30.3bn ($28.02m).
Thank you for subscribing to Clinical Trials Arena